“…Maspin can be down-or upregulated in tumors but the significance of these changes, correlated with maspin subcellular localization, compared with parental tissues, is far to be understood. Most of the published papers refers to maspin expression in carcinomas [4,6,16,17]. In the previously published reports, maspin was examined in particular in breast carcinomas and CRCs, but it was reported to also mark carcinomas of the oral cavity, esophagus, stomach, larynx, lung, pancreas, thyroid, prostate, ovary and urinary bladder [5,6,[17][18][19].…”